Genetic Dissection of Energy Deficiency in Autism Spectrum Disorder
Genes · 2025
DOI: 10.3390/genes16080923 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, 2025. Verfasst von John Jay Gargus. Beteiligte Einrichtung: Medical Genetics and Genomics-Pediatrics, Physiology & Biophysics, Founding Director Center for Autism Research and Translation, University of Califo…. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Energy Metabolism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: An important new consideration when studying autism spectrum disorder (ASD) is the bioenergetic mechanisms underlying the relatively recent rapid evolutionary expansion of the human brain, which pose fundamental risks for mitochondrial dysfunction and calcium signaling abnormalities and their potential role in ASD, as recently highlighted by insights from the BTBR mouse model of ASD. The rapid brain expansion taking place as Homo sapiens evolved, particularly in the parietal lobe, led to increased energy demands, making the brain vulnerable to such metabolic disruptions as are seen in ASD.
Methods
Mitochondrial dysfunction in ASD is characterized by impaired oxidative phosphorylation, elevated lactate and alanine levels, carnitine deficiency, abnormal reactive oxygen species (ROS), and altered calcium homeostasis. These dysfunctions are primarily functional, rather than being due to mitochondrial DNA mutations. Calcium signaling plays a crucial role in neuronal ATP production, with disruptions in inositol 1,4,5-trisphosphate receptor (ITPR)-mediated endoplasmic reticulum (ER) calcium release being observed in ASD patient-derived cells.
Results
This impaired signaling affects the ER–mitochondrial calcium axis, leading to mitochondrial energy deficiency, particularly in high-energy regions of the developing brain. The BTBR mouse model, with its unique Itpr3 gene mutation, exhibits core autism-like behaviors and metabolic syndromes, providing valuable insights into ASD pathophysiology.
Conclusions
Various interventions have been tested in BTBR mice, as in ASD, but none have directly targeted the Itpr3 mutation or its calcium signaling pathway. This review presents current genetic, biochemical, and neurological findings in ASD and its model systems, highlighting the need for further research into metabolic resilience and calcium signaling as potential diagnostic and therapeutic targets for ASD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Genetics and Genomics-Pediatrics, Physiology & Biophysics, Founding Director Center for Autism Research and Translation, University of California, Irvine, CA 92697, USA.
- NeuroQure, 15375 Baranca Parkway, Suite E-104, Irvine, CA 92618, USA.
ORCID-Profile: John Jay Gargus
Zitieren
APA
Gargus, J. J. (2025). Genetic Dissection of Energy Deficiency in Autism Spectrum Disorder. Genes. https://doi.org/10.3390/genes16080923
Vancouver
Gargus JJ. Genetic Dissection of Energy Deficiency in Autism Spectrum Disorder. Genes. 2025. doi:10.3390/genes16080923
BibTeX
@article{Gargus2025,
author = {Gargus, John Jay},
title = {Genetic Dissection of Energy Deficiency in Autism Spectrum Disorder},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16080923}
}
EUVIMED